Literature DB >> 12072078

Generalized pustular and erythrodermic psoriasis associated with bupropion treatment.

N H Cox1, P M Gordon, H Dodd.   

Abstract

Severe drug eruptions may cause diagnostic and therapeutic difficulty when they mimic or provoke endogenous patterns of dermatosis. We report three patients with known psoriasis in whom use of bupropion (Zyban), prescribed to assist with cessation of smoking, led to severe pustular or erythrodermic exacerbation of psoriasis within 3-5 weeks. All patients were systemically unwell and required hospitalization to control the disease flare.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072078     DOI: 10.1046/j.1365-2133.2002.04679.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

Review 1.  Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances.

Authors:  Shuai Shao; Gang Wang; Emanual Maverakis; Johann E Gudjonsson
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

2.  Psoriasis and psycho-dermatology.

Authors:  Hee-Sun Moon; Alexandra Mizara; Sandy R McBride
Journal:  Dermatol Ther (Heidelb)       Date:  2013-07-10

Review 3.  Drug-induced psoriasis: clinical perspectives.

Authors:  Deepak Mw Balak; Enes Hajdarbegovic
Journal:  Psoriasis (Auckl)       Date:  2017-12-07

4.  Erythrodermic psoriasis: pathophysiology and current treatment perspectives.

Authors:  Rasnik K Singh; Kristina M Lee; Derya Ucmak; Merrick Brodsky; Zaza Atanelov; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Wilson Liao
Journal:  Psoriasis (Auckl)       Date:  2016-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.